Siriuspoint Ltd

Aktienanalyse zu Siriuspoint Ltd (SPNT)

$24.180

+0.111 (+0.46%)Zum Schluss

Loading chart…
High
24.470
Open
24.240
VWAP
24.19
Vol
415.79K
Mkt Cap
2.10B
Low
23.925
Amount
10.06M
EV/EBITDA, TTM
6.06

SiriusPoint Ltd. is a Bermuda-based global underwriter of insurance and reinsurance providing solutions to clients and brokers around the world. The Company has licenses to write property and casualty and accident and health insurance and reinsurance globally. The Company’s segments include Reinsurance and Insurance & Services. In the Reinsurance segment, the Company provides reinsurance products to insurance and reinsurance companies, government entities, and other risk-bearing vehicles on a treaty or facultative basis. The Reinsurance segment predominantly underwrites casualty, property and specialty lines of business on a worldwide basis. For reinsurance assumed, it participates in the reinsurance market with a global focus through the broker market distribution channel. Through the Insurance & Services segment, the Company underwrites primary insurance in a number of sectors. The Insurance & Services segment includes accident and health, casualty, and specialty.

AI analysis of Siriuspoint Ltd (SPNT)

buy

Siriuspoint Ltd is a good buy right now due to its current price of $24.18, which is significantly below the analyst price target of $31, suggesting a potential upside. Additionally, the company has shown strong earnings performance with a Q2 EPS of $0.67, exceeding expectations, and a solid forward P/E ratio of 9.63, indicating it is undervalued compared to its earnings potential. The main risk is the slight revenue decline of 0.5% year-over-year in Q2, which could impact future growth.

Bewertungskennzahlen

The current forward P/E ratio for Siriuspoint Ltd (SPNT) is 9.63, compared to its 5-year average forward P/E of 3.98.

Forward P/E

Overvalued
5Y Average P/E
3.98
Current P/E
9.63
Überbewertet
7.74
Unterbewertet
0.23

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
0.71
Current EV/EBITDA
6.06
Überbewertet
2.55
Unterbewertet
-1.14

Forward P/S

Fair
5Y Average P/S
0.83
Current P/S
0.86
Überbewertet
1.76
Unterbewertet
-0.11

Whales holding SPNT

D

Donald Smith & Co., Inc.

+ HoldingSPNT

+13.02%

3M Return

T

Third Point LLC

+ HoldingSPNT

+2.06%

3M Return

P

Punch & Associates Investment Management, Inc.

+ HoldingSPNT

+1.32%

3M Return

Event-Zeitleiste

2026-07-29 (ET)

17:00:00

Company Reports Q2 Revenue of $744.1M

16:31:00

Scott Egan: Q2 Revenue $744.1 Million

2026-07-16 (ET)

16:30:00

SiriusPoint Appoints Emily Yoo as COO

2026-03-16 (ET)

07:40:00

SiriusPoint Restructures Business into Four Divisions

2026-02-18 (ET)

16:30:00

SiriusPoint Reports Q4 Book Value Per Share of $18.10

News

SPNT FAQ — answered by Alphio AI

SiriusPoint Ltd. is a Bermuda-based global underwriter of insurance and reinsurance providing solutions to clients and brokers around the world. The Company has licenses to write property and casualty and accident and health insurance and reinsurance globally. The Company’s segments include Reinsurance and Insurance & Services. In the Reinsurance segment, the Company provides reinsurance products to insurance and reinsurance companies, government entities, and other risk-bearing vehicles on a treaty or facultative basis. The Reinsurance segment predominantly underwrites casualty, property and specialty lines of business on a worldwide basis. For reinsurance assumed, it participates in the reinsurance market with a global focus through the broker market distribution channel. Through the Insurance & Services segment, the Company underwrites primary insurance in a number of sectors. The Insurance & Services segment includes accident and health, casualty, and specialty. It operates in the Financials sector (FIRE, MARINE & CASUALTY INSURANCE industry).

Siriuspoint Ltd is a good buy right now due to its current price of $24.18, which is significantly below the analyst price target of $31, suggesting a potential upside. Additionally, the company has shown strong earnings performance with a Q2 EPS of $0.67, exceeding expectations, and a solid forward P/E ratio of 9.63, indicating it is undervalued compared to its earnings potential. The main risk is the slight revenue decline of 0.5% year-over-year in Q2, which could impact future growth.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten